XGS-13362-14150 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-10
Dose 1 — Janssen/Johnson & Johnson
2021-03-11
Registered in v-safe
2021-03-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-03-19
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-02
Health check-in — day 21, single dose
Feeling: Fair

Adult check-in
2021-04-15
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-11-11
Dose 2 — Moderna
2022-03-10
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in
2022-09-18
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-11-13
Survey response — 12 months, dose 2
MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Pregnancy

MedDRA releases: 2024-11 · check-in free text available
2022-11-13
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-14
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-12-18
Survey response — 3 months, dose 3
MedDRA: Headache, Upper-airway cough syndrome — Feeling: Fair

Free text: Light headache, post nasal drip

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-10	Janssen/Johnson & Johnson
2	2021-11-11	Moderna	No
3	2022-09-18	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2022-11-13	Successful 2022-11-14	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 — 12 months, dose 2

2022-11-13

Symptoms: Pregnancy

Release 12 — 3 months, dose 3

2022-12-18

Symptoms: Light headache, post nasal drip

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	·	·	✓
SD	Pregnancy	·	·	✓
SD	Upper-airway cough syndrome	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release